EMN
49
3
GLW
48
2
NWSA
78
5
GILD
62
2
MAS
59
3
LOW
53
3
FOXA
63
3
NSC
53
6
JCI
45
4
TJX
43
3
ROK
42
4
XYL
35
4
AIZ
54
7
K
56
5
HD
49
5
HRB
56
2
CMI
59
14
SLB
45
4
HBI
52
2
AMGN
42
-5
EMN
49
3
GLW
48
2
NWSA
78
5
GILD
62
2
MAS
59
3
LOW
53
3
FOXA
63
3
NSC
53
6
JCI
45
4
TJX
43
3
ROK
42
4
XYL
35
4
AIZ
54
7
K
56
5
HD
49
5
HRB
56
2
CMI
59
14
SLB
45
4
HBI
52
2
AMGN
42
-5
Financhill
Back

Apellis Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
28.11
Seasonality Move:
22.1%
Buy
54

BMRN
Biomarin Pharmaceutical

Last Price:
66.03
Seasonality Move:
13.3%
Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $28.08. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $66.04. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $28.08
    The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $66.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 45.96 Sell
Chaikin Money Flow: 8609149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.04 - 28.04) Buy
Bollinger Bands (100): (30.03 - 39.99) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.96 Sell
Relative Strength Index (14 RSI): 29.66 Sell
Chaikin Money Flow: 826493 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.58 - 70.68) Sell
Bollinger Bands (100): (71.66 - 88.44) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.62 Buy
20-day SMA: 27.47 Buy
50-day SMA: 31.83 Sell
200-day SMA: 44.76 Sell
8-day EMA: 27.81 Buy
20-day EMA: 28.14 Sell
50-day EMA: 30.87 Sell
200-day EMA: 40.98 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.62 Sell
20-day SMA: 69.09 Sell
50-day SMA: 74.56 Sell
200-day SMA: 82.71 Sell
8-day EMA: 67.29 Sell
20-day EMA: 68.99 Sell
50-day EMA: 73.26 Sell
200-day EMA: 81.42 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.29 per share, and an increase next year of $1.33 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):